Pioneering a new wave of oncology treatment

Immuno-oncology meets global science and big data

Why we come to work each day

Chimeric Antigen Receptor (CAR)-T cell therapy has already delivered remarkable on-target responses to certain hematological malignancies. Through our partnership with BioAtla, we are taking CAR-T to the next step by harnessing the power of the immune system to target some of the most challenging solid tumor malignancies.

Innovation is at the core of our global network

From Shanghai to San Diego to West Palm Beach to Grand Cayman: We are integrated over 12 hours of time zones because cancer never sleeps, and neither does the data.

Be a part of something amazing

We are a rapidly growing global startup looking for entrepreneurially-minded, dedicated, and ambitious individuals to join our team of biotech rockstars who want to make a real difference in the fight against cancer. If this sounds like you, please check out our openings below.